Panacea Index Logo

Command Palette

Search for a command to run...

Time course of strength adaptations following high-intensity resistance training in individuals with multiple sclerosis.

European journal of applied physiology
April 1, 2017
A Manca et al. (6 authors)
Clinical TrialJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the time course and clinical relevance of muscle strength improvements from high-intensity resistance training in people with multiple sclerosis (PwMS) and its impact on muscle endurance, mobility, and walking outcomes.

Results Summary

Significant strength gains were observed after 3 weeks of training, correlating with improved muscle endurance and mobility, but these benefits were not sustained at the 12-week follow-up.

Population

People with multiple sclerosis (PwMS) exhibiting predominantly unilateral weakness in ankle dorsiflexors.

Effective Dosage

6-week isokinetic training of the more affected ankle dorsiflexion muscles (specific intensity/frequency not detailed).

Duration

6 weeks (intervention), with follow-up at 12 weeks.

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
6-week isokinetic training of the more affected ankle dorsiflexion muscles
increase
muscle strength
people with multiple sclerosis (PwMS) with predominantly unilateral hyposthenia of the ankle dorsiflexors
-
significant gains
#1
high-intensity resistance training
increase
muscle endurance to fatigue
people with multiple sclerosis (PwMS) with predominantly unilateral hyposthenia of the ankle dorsiflexors
-
improvements
#2
high-intensity resistance training
increase
mobility measures
people with multiple sclerosis (PwMS) with predominantly unilateral hyposthenia of the ankle dorsiflexors
-
improvements
#3
6-week isokinetic training of the more affected ankle dorsiflexion muscles
no change
muscle performance
people with multiple sclerosis (PwMS) with predominantly unilateral hyposthenia of the ankle dorsiflexors
-
none of the observed changes was retained
#4
6-week isokinetic training of the more affected ankle dorsiflexion muscles
no change
functional outcomes
people with multiple sclerosis (PwMS) with predominantly unilateral hyposthenia of the ankle dorsiflexors
-
none of the observed changes was retained
#5
3 weeks of high-intensity resistance training
increase
muscle performance of the ankle dorsiflexors
people with multiple sclerosis (PwMS)
-
induces consistent and meaningful improvements
#6
Abstract

PURPOSE: No evidence exists regarding the time course and clinical relevance of muscle strength improvements following resistance training in people with multiple sclerosis (PwMS). The purpose of this study was to investigate the temporal course and the clinical meaningfulness of the changes in strength induced by high-intensity resistance training and whether these changes impact on muscle endurance to fatigue and functional outcomes. METHODS: PwMS with predominantly unilateral hyposthenia of the ankle dorsiflexors underwent a 6-week isokinetic training of the more affected ankle dorsiflexion muscles. Maximal strength was measured at baseline, during the training on a weekly basis, at the end of the intervention (POST) and at the 12-week follow-up. Muscle endurance to fatigue, mobility and walking outcomes were assessed at baseline, POST and follow-up. Reproducibility and responsiveness analyses were performed. RESULTS: Significant gains in muscle strength were already detected after 3 weeks of training with no further improvements in the following weeks. These improvements exceeded the cutoff values for relevant changes and were also positively correlated to improved muscle endurance to fatigue and mobility measures. None of the observed changes in muscle performance and functional outcomes was retained at the follow-up. CONCLUSIONS: Preliminary evidence showed that 3 weeks of high-intensity resistance training induces consistent and meaningful improvements in muscle performance of the ankle dorsiflexors in PwMS. These findings may have practical dose-response and cost-effectiveness implications in the management of MS-induced muscle weakness, potentially enhancing the understanding of the response to training exhibited by PwMS. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier NCT02010398; December 2013.

Medical Subject Headings (MeSH)
Adaptation, PhysiologicalAdultFemaleHigh-Intensity Interval TrainingHumansMaleMiddle AgedMultiple SclerosisMuscle FatigueMuscle StrengthReaction TimeWalking
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations11
Citations/Year1.4
Relative Citation Ratio0.76
NIH Percentile40.3%
Research Impact Scores
APT Score0.50
Weight Score1.83
Normalized Score0.69
Related Supplements